PubMed
Consulter la page PubMed :
Extrait de nos publications
Type-1 cytokines regulate matrix metalloprotease-9 production and E-cadherin disruption to promote melanocyte loss in vitiligo.
JCI Insight, 2020 Jun 4;5(11):e133772.
➜ Accès DOI
NKG2D Defines a Subset of Skin Effector Memory CD8 T Cells with Proinflammatory Functions in Vitiligo.
J Invest Dermatol., 2020 Jun;140(6):1143-1153.e5.
➜ Accès DOI
Imbalance of peripheral follicular helper T lymphocyte subsets in active vitiligo.
Pigment Cell Melanoma Res., 2019 Jul;32(4):588-592.
➜ Accès DOI
Vitiligo Skin Is Imprinted with Resident Memory CD8 T Cells Expressing CXCR3.
J. Invest Dermatol., 2018 Feb;138(2):355-364.
➜ Accès DOI
Heat shock protein 70 potentiates interferon alpha production by plasmacytoid dendritic cells: relevance for cutaneous lupus and vitiligo pathogenesis.
Br J Dermatol., 2017 Nov;177(5):1367-1375.
➜ Accès DOI
Cross cultural validation of a short-form of the Vitiligo Impact Patient scale (VIPs).
J Am Acad Dermatol., 2019 Nov;81(5):1107-1114.
➜ Accès DOI
Vitiligo as a skin memory disease: The need for early intervention with immunomodulating agents and a maintenance therapy to target resident memory T cells.
Exp Dermatol., 2019 Jun;28(6):656-661.
➜ Accès DOI
Vitiligo: Focus on Clinical Aspects, Immunopathogenesis, and Therapy.
Clin Rev Allergy Immunol., 2018 Feb;54(1):52-67.
➜ Accès DOI
Vitiligo
Lancet, 2015 Jul 4;386(9988):74-84.
➜ Accès DOI
Vitiligo: clinical practice
NEJM, 2009 Jan 8;360(2):160-9.
➜ Accès DOI